We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTHX
4026
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$1.04M ﹤0.01%
42,998
-109,383
-72% -$1.81M
MR
4027
DELISTED
Montage Resources Corporation Common Stock
MR
$1.04M ﹤0.01%
263,846
+256,053
+3,286% +$1.31M
MFM
4028
Aberdeen Municipal Income Fund
MFM
$221M
$1.04M ﹤0.01%
166,823
-12,139
-7% -$73.6K
OYST
4029
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$1.04M ﹤0.01%
36,034
+35,599
+8,184% +$1.07M
LGF.A
4030
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$1.04M ﹤0.01%
140,445
+45,932
+49% +$340K
DRD
4031
DRDGold
DRD
$1.98B
$1.04M ﹤0.01%
65,635
+60,941
+1,298% +$602K
REPL icon
4032
Replimune Group
REPL
$1B
$1.03M ﹤0.01%
41,553
+38,327
+1,188% +$678K
CORP icon
4033
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.58B
$1.03M ﹤0.01%
9,021
-5,286
-37% -$586K
TFSL icon
4034
TFS Financial
TFSL
$5.17B
$1.03M ﹤0.01%
72,073
-6,268
-8% -$90.3K
VSTM icon
4035
Verastem
VSTM
$518M
$1.03M ﹤0.01%
49,852
+47,634
+2,148% +$1.26M
SAL
4036
DELISTED
Salisbury Bancorp, Inc.
SAL
$1.03M ﹤0.01%
50,252
-1,126
-2% -$20.4K
CENT icon
4037
Central Garden & Pet Co
CENT
$2.76B
$1.03M ﹤0.01%
35,613
+1,339
+4% +$36K
VIE
4038
DELISTED
Viela Bio, Inc. Common Stock
VIE
$1.02M ﹤0.01%
23,634
+13,848
+142% +$627K
PFL
4039
PIMCO Income Strategy Fund
PFL
$386M
$1.02M ﹤0.01%
105,315
-51,800
-33% -$475K
DTP
4040
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
$1.02M ﹤0.01%
24,008
+5,983
+33% +$248K
FAZ
4041
Direxion Daily Financial Bear 3x ETF
FAZ
$84.4M
$1.01M ﹤0.01%
57,298
+50,042
+690% +$886K
RGP icon
4042
Resources Connection
RGP
$154M
$1.01M ﹤0.01%
84,776
-13,120
-13% -$142K
REX icon
4043
REX American Resources
REX
$1.45B
$1.01M ﹤0.01%
87,732
-156
-0.2% -$1.55K
BCRX icon
4044
BioCryst Pharmaceuticals
BCRX
$2.3B
$1.01M ﹤0.01%
212,393
-479,755
-69% -$1.92M
TMF icon
4045
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
$2.2B
$1.01M ﹤0.01%
2,489
-1,325
-35% -$551K
IVC
4046
DELISTED
Invacare Corporation
IVC
$1.01M ﹤0.01%
158,997
+34,245
+27% +$229K
TMUSR
4047
DELISTED
T-Mobile US, Inc. Subscription Rights Expiring 7/27/2020
TMUSR
$1.01M ﹤0.01%
+6,017,828
New +$1.69M
HVT icon
4048
Haverty Furniture Companies
HVT
$460M
$1.01M ﹤0.01%
63,094
+9,849
+18% +$144K
MOTI icon
4049
VanEck Morningstar International Moat ETF
MOTI
$75.8M
$1.01M ﹤0.01%
35,767
-851
-2% -$22.7K
IBA
4050
DELISTED
Industrias Bachoco SAB De C.V.
IBA
$1.01M ﹤0.01%
28,716
+4,015
+16% +$138K

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.